FSMAX
Price
$94.93
Change
-$0.10 (-0.11%)
Updated
Aug 5 closing price
Net Assets
39.63B
TRMNX
Price
$22.42
Change
-$0.10 (-0.44%)
Updated
Aug 5 closing price
Net Assets
306.89M
Interact to see
Advertisement

FSMAX vs TRMNX

Header iconFSMAX vs TRMNX Comparison
Open Charts FSMAX vs TRMNXBanner chart's image
Fidelity Extended Market Index
Price$94.93
Change-$0.10 (-0.11%)
VolumeN/A
Net Assets39.63B
T. Rowe Price Mid-Cap Index
Price$22.42
Change-$0.10 (-0.44%)
VolumeN/A
Net Assets306.89M
FSMAX vs TRMNX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMAX vs. TRMNX commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and TRMNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.6B vs. TRMNX (307M). FSMAX pays higher dividends than TRMNX: FSMAX (0.46) vs TRMNX (0.43). FSMAX was incepted earlier than TRMNX: FSMAX (14 years) vs TRMNX (10 years). TRMNX (0.30) is less costly to investors than FSMAX (0.04). TRMNX is a more actively managed with annual turnover of: 31.70 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than TRMNX: FSMAX (0) vs TRMNX (2500). TRMNX annual gain was more profitable for investors over the last year : 28.00 vs. FSMAX (21.86). TRMNX return over 5 years is better than : 57.29 vs. FSMAX (52.00).
FSMAXTRMNXFSMAX / TRMNX
Total Expense Ratio0.040.2713%
Annual Report Gross Expense Ratio0.040.3012%
Fund Existence14 years10 years-
Gain YTD4.5668.06157%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets39.6B307M12,899%
Annual Yield % from dividends0.460.43108%
Returns for 1 year21.8628.0078%
Returns for 3 years38.8446.5983%
Returns for 5 years52.0057.2991%
Returns for 10 years84.21N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LE13.130.46
+3.63%
Lands' End
HALO60.810.82
+1.37%
Halozyme Therapeutics
CHSCP28.590.07
+0.23%
CHS
ICCC6.18-0.06
-0.96%
ImmuCell Corp
SRPT16.75-0.35
-2.05%
Sarepta Therapeutics